Lenalidomide With or Without Erythropoietin in Transfusion-Dependent Erythropoiesis-Stimulating Agent-Refractory Lower-Risk MDS Without 5q Deletion
Leukemia - United Kingdom
doi 10.1038/leu.2015.296
Full Text
Open PDFAbstract
Available in full text
Date
October 26, 2015
Authors
Publisher
Springer Science and Business Media LLC